The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of November 2020. This month is one guideline and one medtech innovation briefing that impact upon primary care.
The Human and animal bites: antimicrobial prescribing guideline has been published. It sets out an antimicrobial prescribing strategy for human and animal bites (excluding insect bites) in adults, young people and children aged 72 hours and over. It aims to optimise antibiotic use and reduce antibiotic resistance.
The Dexcom G6 for real-time continuous glucose monitoring medtech innovation briefing has been published. This briefing notes that the intended place in therapy is as an alternative to routine blood glucose monitoring in people (over 2 years old), including pregnant women, with type 1 or type 2 diabetes, who use multiple daily insulin injections or use insulin pumps and are self-managing their diabetes. The available evidence notes that this device reduces interstitial fluid glucose levels and the time spent in hypoglycaemia compared with self-monitoring of blood glucose using finger-prick testing. It is noted that lifetime costs for this device are likely to be higher compared to finger-prick testing but this may be balanced by avoiding the costs associated with short-term and long-term clinical outcomes of poorly managed diabetes.
Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.